Phase II Study of Panitumumab Monotherapy in Chemotherapy-Naïve Frail or Elderly Patients with Unresectable RAS Wild-Type Colorectal Cancer: OGSG 1602.

Tetsuji TerazawaTakeshi KatoMasahiro GotoKatsuya OhtaShingo NouraHironaga SatakeYoshinori KagawaHisato KawakamiHiroko HasegawaKazuhiro YanagiharaTatsushi ShingaiKen NakataMasahito KotakaMasayuki HirakiKen KonishiShiro NakaeDaisuke SakaiYukinori KurokawaToshio ShimokawaTaroh Satoh

Published in: The oncologist (2020)

Panitumumab monotherapy showed favorable efficacy and feasibility in frail or elderly patients with RAS WT unresectable CRC. Survival analysis including OS, PFS, and TTF is currently in progress.

Keyphrases

wild type
locally advanced
phase ii study
community dwelling
rectal cancer
open label
squamous cell carcinoma
radiation therapy
combination therapy
middle aged
liver metastases
clinical trial
randomized controlled trial
free survival